ScreenIT
The Automated Screening Working Groups is a group of software engineers and biologists passionate about improving scientific manuscripts on a large scale. Our members have created tools that check for common problems in scientific manuscripts, including information needed to improve transparency and reproducibility. We have combined our tools into a single pipeline, called ScreenIT. We're currently using our tools to screen COVID preprints.
Latest preprint reviews
-
The Effect of COVID-19 Diagnosis on the Physical, Social, and Psychological Well-Being of People in the United Arab Emirates: An Explorative Qualitative Study
This article has 5 authors:Reviewed by ScreenIT
-
Mutational Signatures as Sensors of Environmental Exposures: Role of Smoking in COVID-19 Vulnerabilities
This article has 6 authors:Reviewed by ScreenIT
-
Nasopharyngeal Microbiota as an early severity biomarker in COVID-19 hospitalised patients
This article has 12 authors:Reviewed by ScreenIT
-
ChAdOx1 nCoV-19 vaccine elicits monoclonal antibodies with cross-neutralizing activity against SARS-CoV-2 viral variants
This article has 18 authors:Reviewed by ScreenIT
-
BNT162b2 vaccination induces durable SARS-CoV-2–specific T cells with a stem cell memory phenotype
This article has 16 authors:Reviewed by ScreenIT
-
Burden of Covid-19 restrictions: National, regional and global estimates
This article has 3 authors:Reviewed by ScreenIT
-
A standardized instrument quantifying risk factors associated with bi-directional transmission of SARS-CoV-2 and other zoonotic pathogens: The COVID-19 human-animal interactions survey (CHAIS)
This article has 7 authors:Reviewed by ScreenIT
-
Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence and Reported Coronavirus Disease 2019 Cases in US Children, August 2020–May 2021
This article has 20 authors:Reviewed by ScreenIT
-
Analysis of the ARTIC Version 3 and Version 4 SARS-CoV-2 Primers and Their Impact on the Detection of the G142D Amino Acid Substitution in the Spike Protein
This article has 9 authors:Reviewed by ScreenIT
-
Induction of robust neutralizing antibodies against the COVID-19 Delta variant with ChAdOx1 nCoV-19 or BNT162b2 as a booster following a primary vaccination series with CoronaVac
This article has 3 authors:Reviewed by ScreenIT